ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer

Preventive therapy can target hormone-responsive breast cancer (BC) by treatment with selective estrogen receptor modulators (SERMs) and reduce the incidence of BC. Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) with relevant predictive values, SNPs in the ZNF...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Endocrinol (Lausanne)
Main Authors: Bond, Heather M., Scicchitano, Stefania, Chiarella, Emanuela, Amodio, Nicola, Lucchino, Valeria, Aloisio, Annamaria, Montalcini, Ylenia, Mesuraca, Maria, Morrone, Giovanni
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2018
Teme:
Endocrinology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5968090/
https://ncbi.nlm.nih.gov/pubmed/29867779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00255
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki